Delving into discrepancies, a single-center experience with Accelerate Pheno for gram-negative bacteremia, a rapid phenotypic susceptibility testing method
Open Access
- 23 January 2025
- journal article
- research article
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e15
Abstract
Objective: Discrepancies or inaccuracies between testing methods can create confusion or lead to clinical harm if antibiotics are inappropriately chosen. We report our clinical experience using the Accelerate Pheno™ followed by routine automated susceptibilities by the Vitek®2 for positive blood cultures with gram-negative rods. Design: This was a retrospective review of positive gram-negative blood cultures, including comparison of susceptibility testing results and impact on clinical care. Setting: Academic teaching hospital. Patients (participants): All patients admitted to the hospital with gram-negative bacteremia from January 2020 to December 2022. Methods: Microbiology was reviewed for discrepancies as defined by very major errors (VMEs), major errors (MEs), and minor errors (mEs). Clinical charts were reviewed for antibiotic therapy. Results: Positive blood cultures with gram-negative rods were included (n = 262). Between these two methods, overall essential agreement was 93.7% (2162/2304) and categorical agreement 93.5% (2159/2306). There were 147 discrepancies noted, including 6 VMEs, 25 MEs, and 116 mEs accounting for 96 patients. Antibiotic choice was changed in 8 patients due to perceived suboptimal empiric therapy based on the rapid susceptibility results. Conclusions: The Accelerate Pheno tended to over-call resistance compared to the Vitek®2. Few patients (8) received the incorrect antibiotic based on the Pheno result. Stewardship programs may choose to optimize their rapid antibiotic susceptibility testing reporting to help minimize confusion and guide appropriate antibiotic selection.Keywords
This publication has 26 references indexed in Scilit:
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC KitJournal of Antimicrobial Chemotherapy, 2021
- Implementation of a Rapid Phenotypic Susceptibility Platform for Gram-Negative Bloodstream Infections With Paired Antimicrobial Stewardship Intervention: Is the Juice Worth the Squeeze?Clinical Infectious Diseases, 2021
- Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremiaInfection, 2021
- Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trialClinical Microbiology and Infection, 2021
- Clinical Performance and Impact of Accelerate Pheno for Gram-negative Bacteremia in Hospitalized ChildrenClinical Therapeutics, 2020
- Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic PatientsClinical Infectious Diseases, 2020
- Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GNClinical Infectious Diseases, 2020
- Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremiaJournal of Infection, 2014
- Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitalsJournal of Antimicrobial Chemotherapy, 2003